J.P. Morgan 2019: Outlook for biotech, gene therapy looks positive

2019 01 04 20 52 7002 San Francisco Golden Gate 400

SAN FRANCISCO - The outlook for the gene therapy industry appears to be positive for the coming year, according to a Monday presentation in the Biotech Showcase, part of this week's J.P. Morgan Healthcare Conference. In a separate talk, presenters discussed the "booming" biotech industry and whether the sector's frenetic growth could be a sign of looming turbulence.

Page 1 of 7
Next Page